Jeff Castleberry

Endoshape Inc

$2,494,377

Attributed

$2,494,377

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2008–20

$2M$1.5M$1M$500K$0

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NSF$2,494,377 · 4

By mechanism

—$2,494,377 · 4

Top collaborators

No co-investigators on record.

Grant awards (4)

SBIR Phase II: Antibiotic-Dispensing Spacer for Improved Periprosthetic Joint Infection (PJI) Treatment$1,194,923

· FY2020 · TIP · contact PI

SBIR Phase I: Antibiotic Dispensing Spacer for improved treatment of PJI in TKA$224,872

· FY2019 · TIP · contact PI

SBIR Phase II: Novel SMP-based TCD Devices$500,000

· FY2009 · TIP · contact PI

SBIR Phase II: Shape memory polymer AAA Endograft$574,582

· FY2008 · TIP · contact PI